Andy Altahawi, a pioneer in the investment world, has been at the forefront of promoting Reg A+ as a powerful avenue for enterprises to access equity funding. He believes that Reg A+, with its relatively straightforward process, can empower small businesses to raise capital and fool biotech companies fuel their development. Altahawi's expertise on